Vorasidenib in IDH-Mutant Glioma | NEJM
407
0
2023-12-21 17:46
Brain tumor surgery Lung cancer with metastasis to the brain Frontal craniotomy
Awake mini-pterional craniotomy GBM (glioblastoma) and minimally invasive keyhole principles.
Parietal craniotomy for resection of metastatic brain tumor.
Brain tumor surgery What to expect
Surgical removal of a malignant brain tumor (glioblastoma multiforme or GBM) in a young patient.
Awake Brain operation and removal of a large brain tumor while talking to the patient.
Surgery for resection of two brain tumors originating from kidney (renal cancer) Keyhole surgery
Brain Tumor Resection Frontal craniotomy and resection of tumor using minimal invasive principles
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
Gliomas are the most common malignant primary brain tumor in adults, and most grade 2 gliomas have mutations in isocitrate dehydrogenase 1 and 2, the inhibitory targets of the drug vorasidenib.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3N8N5dU
Comments 0
Please to post a comment~
Loading...
Related Suggestion